Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalized vs Standardized Opioid Prescriptions in Orthognathic Surgery
NCT05708521Phase 4Active, not recruiting
- Sponsor
- Nova Scotia Health
- Start
- Apr 2023
- Primary completion
- May 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of hydromorphone in postoperative pain (2 arms), sponsored by Nova Scotia Health. Primary endpoints: Fraction of remaining unused opioid and Absolute amount of remaining unused opioid. Started Apr 2023; status: active, not recruiting.
02
Drugs
hydromorphone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05708521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05708521.